Eternygen GmbH

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar

Venture capital investment in US biopharmaceutical companies fell $2.1bn from $9.89bn in 2015 to $7.79bn in 2016, but it was still the second highest amount of VC cash invested in US drug development

Hamburg-based Evotec AG has risen like a Phoenix from the ashes in recent years to become a profitable drug-discovery business whose growth is driven by the rising trend toward outsourcing, as Big

IN VITRO DIAGNOSTICS Alliances Abbott Laboratories Inc. Idera Pharmaceuticals Inc. Idera Pharmaceuticals Inc. (toll-like receptor (TLR) antagonists for autoimmune diseases and B-cell lymphomas) si